These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11109869

  • 1. Polypharmacy and non-compliance in the hypertensive elderly patient.
    Fonseca T, Clara JG.
    Rev Port Cardiol; 2000 Sep; 19(9):855-72. PubMed ID: 11109869
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians.
    Amira CO, Okubadejo NU.
    Niger Postgrad Med J; 2007 Dec; 14(4):325-9. PubMed ID: 18163143
    [Abstract] [Full Text] [Related]

  • 3. [Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany].
    Rottlaender D, Scherner M, Schneider T, Erdmann E.
    Dtsch Med Wochenschr; 2007 Jan 26; 132(4):139-44. PubMed ID: 17230328
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
    Small RE, Freeman-Arnold SB, Goode JV, Pyles MA.
    Pharmacotherapy; 1997 Jan 26; 17(5):1011-6. PubMed ID: 9324190
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P, Guilhot J, Tilly B, Salanave B, Allemand H.
    Therapie; 2001 Jan 26; 56(2):111-8. PubMed ID: 11471361
    [Abstract] [Full Text] [Related]

  • 6. [Cross-national comparison of drug compliance and non-compliance associated factors in the elderly with polypharmacotherapy].
    Topinková E, Fialová D, Carpenter GI, Bernabei R.
    Cas Lek Cesk; 2006 Jan 26; 145(9):726-32. PubMed ID: 17091729
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM.
    Rev Port Cardiol; 2009 May 26; 28(5):499-523. PubMed ID: 19650569
    [Abstract] [Full Text] [Related]

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 26; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 9. [Polypharmacotherapy in the elderly hypertensive patient].
    Alvarez A, Clara JG.
    Rev Port Cardiol; 1994 Apr 26; 13(7-8):587-92, 563. PubMed ID: 7917404
    [Abstract] [Full Text] [Related]

  • 10. Ethnic differences in antihypertensive medication use in the elderly.
    Raji MA, Kuo YF, Salazar JA, Satish S, Goodwin JS.
    Ann Pharmacother; 2004 Feb 26; 38(2):209-14. PubMed ID: 14742752
    [Abstract] [Full Text] [Related]

  • 11. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E, Hedner T, Jönsson B, Ekbom T, Lindholm LH, Dahlöf B, de Faire U, Scherstén B, Stop-2 Hypertension Group.
    Blood Press; 2005 Feb 26; 14(2):107-13. PubMed ID: 16036488
    [Abstract] [Full Text] [Related]

  • 12. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
    Xu KT, Moloney M, Phillips S.
    Am J Manag Care; 2003 Aug 26; 9(8):529-36. PubMed ID: 12921230
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.
    Pharmacoepidemiol Drug Saf; 2001 May 26; 10(3):219-27. PubMed ID: 11501335
    [Abstract] [Full Text] [Related]

  • 14. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
    Ahmed N, Abdul Khaliq M, Shah SH, Anwar W.
    J Ayub Med Coll Abbottabad; 2008 May 26; 20(2):66-9. PubMed ID: 19385461
    [Abstract] [Full Text] [Related]

  • 15. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec 26; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

  • 16. Drug treatment of hypertension: compliance and adverse reactions in a cohort of hypertensive patients in a primary care setting.
    Mino-León D, Reyes-Morales H, Galván-Plata ME, Ponce-Monter H, Palma-Aguirre JA, Amato D, Figueras A.
    Rev Invest Clin; 2007 Dec 26; 59(1):8-14. PubMed ID: 17569295
    [Abstract] [Full Text] [Related]

  • 17. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study].
    Marques-Vidal P, Arveiler D, Amouyel P, Ducimetière P, Ferrières J.
    Rev Epidemiol Sante Publique; 2001 Dec 26; 49(6):541-9. PubMed ID: 11845103
    [Abstract] [Full Text] [Related]

  • 18. Drug compliance among hypertensive patients in Kassala, eastern Sudan.
    Elzubier AG, Husain AA, Suleiman IA, Hamid ZA.
    East Mediterr Health J; 2000 Jan 26; 6(1):100-5. PubMed ID: 11370321
    [Abstract] [Full Text] [Related]

  • 19. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB, Kranjcević K, Reiner Z, Blazeković SM, Spehar SS.
    Croat Med J; 2005 Dec 26; 46(6):984-9. PubMed ID: 16342354
    [Abstract] [Full Text] [Related]

  • 20. Doctor pharmaceutical utilization behaviour changed by the global budget programme strategies on hypertensive outpatient prescription.
    Wei CK, Wang SM, Yeh MK.
    J Eval Clin Pract; 2012 Apr 26; 18(2):262-8. PubMed ID: 21040251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.